Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect

Abstract

Background. Few studies have evaluated the epidemiology and effect of pain in ambulatory patients with cancer who are undergoing active therapy. This information is needed to develop strategies for supportive care in this population. Methods. The prevalence and characteristics of pain were determined in a prospective survey of ambulatory patients with lung or colon cancer. To reduce bias and acquire comprehensive information, the methodology used face‐to‐face interviews by trained quality assurance analysts, a multifaceted assessment instrument, and multivariate statistical analysis. Results. In a telephone interview, “persistent or frequent” pain during the previous 2 weeks was reported by 57 of 145 (39.3%) patients with lung cancer and 52 of 181 (28.7%) patients with colon cancer; 91 of these patients (47 lung and 44 colon) were interviewed in detail. All patients had excellent performance status, and with the exception of pain location, there were no significant differences between the two tumor types. One‐third of the patients had more than one discrete pain. Median pain duration was 4 weeks (range, less than 1 week‐468 weeks), and average pain intensity was moderate. Approximately 90% of patients experienced pain more than 25% of the time. Pain interfered moderately or more with general activity and work in approximately half of the patients; more than half reported moderate or greater pain interference in sleep, mood, and enjoyment of life. Multiple regression analysis revealed that the daily frequency of pain, the intensity of the worst pain, the score on a mood scale, and the frequency of the worst pain accounted for 58.7% of the variance in average pain intensity. Likewise, 52.1% of the variance in a derived measure of pain interference in function was explained by the mood score, frequency of the worst pain, number of pains, and pain intensity. Conclusions. These data indicate that pain is prevalent among well‐functioning ambulatory patients and substantially compromises function in approximately half of the patients who experience it. Pain is a complex symptom; aspects other than intensity, such as frequency, strongly influence its effect.

Characterization of cancer-induced bone pain: an exploratory study

“…The interference section assesses the effect of pain on general activity, mood, walking, work, relationships, sleep and enjoyment of life, using a 0-10 NRS, where 0 indicates no interference by pain and 10 indicates that pain completely interferes with the specific component. The BPI interference score (sum of individual interference question scores) gives a useful indicator of the effect of pain on physical, psychological and social function [22]. The BPI can be assessed using individual questions in isolation (e.g.…”

Adjuvant Analgesics in Cancer Pain Management

“…Approximately one-third of patients have pain while undergoing active therapy for the disease, and more than three-quarters have pain during the last stages of illness [1,2]. Fortunately, experience suggests that cancer pain can be relieved in more than 70% of patients using a simple opioid-based regimen [3][4][5].…”

Avaliação da S(+) cetamina por via oral associada à morfina no tratamento da dor oncológica

“…Some authors stated that one third of the patients complain of pain in more than one location, while others report that up to 81% of the patients complain of pain in two or more locations [21][22][23] . In the first appointment, 82.5% of the patients complained of moderate to severe pain according to the verbal scale, which is very close to some studies that showed that more than 60% of the patients complain of pain of the same severity 21,24 .…”